During the past decade, Oregon Stroke Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oregon Stroke Center" are "Acute Ischemic Stroke" (1 trials), "Carotid Artery Disease" (1 trials) and "Ischemic Stroke" (1 trials). Many other conditions were trialed in "Oregon Stroke Center" in a lesser frequency.

Most popular intervention types in "Oregon Stroke Center" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carotid WALLSTENT Monorail Endoprosthesis" (1 trials), "FilterWire EZ™ System™" (1 trials), "MERCI® Device" (1 trials), "SOLITAIRE™ Device" (1 trials) and "alfimeprase" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oregon Stroke Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Oregon Stroke Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Oregon Stroke Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oregon Stroke Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".